Headache News

Half of people with migraine reported being “extremely dissatisfied” with their ability to control their disease in a survey from the National Headache Foundation, while most patients on a preventive treatment wished for better options.

The American Academy of Neurology released an update to their 2014 position statement on telehealth in which they reiterate their call for expanding its use.

Aimovig monotherapy demonstrated sustained efficacy up to 64 weeks among patients with episodic migraine who were unsuccessfully treated with multiple other preventive therapies, according to study findings published in Neurology.

Almost 14% of patients with reversible cerebral vasoconstriction syndrome had non-elective hospital readmissions within 90 days of discharge, according to an analysis of more than 1,100 hospitalizations in 2016 and 2017.

Treatment with Vyepti during a migraine provided earlier freedom from headache pain and most bothersome migraine symptoms — either photophobia, phonophobia or nausea — compared with placebo, according to results from the RELIEF study.

In this video perspective, Jessica Ailani, MD, discusses results from a phase 3 trial of atogepant for the prevention of migraine that were presented during the American Academy of Neurology annual meeting, which is being held virtually.

Women with migraine had an increased risk for hypertension after menopause, but there were no significant differences between migraine with and without aura, according to a longitudinal cohort study launched in 1990.

Migraine diagnoses, treatment and management varied by race and sex among a sample of patients that was “evenly distributed” across the country, according to researchers. 

Research into biomarkers to identify concussion and differentiate ischemic stroke from intracerebral hemorrhage topped Healio Neurology’s coverage in March. Plus: cannabis use, neuroplasticity after stroke and Lewy body dementia.

Non-hospitalized ‘long hauler’ patients with COVID-19 experienced “prominent and persistent” neurological symptoms, including brain fog and fatigue, according to results published in Annals of Clinical and Translational Neurology.